Clinical Trials in Georgia

Showing 18061-18080 of 19,050 trials

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

NCT00083486

The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.

Anemia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Started Feb 2004

Hot Springs, Arkansas, United States • Griffin, Georgia, United States • Centralia, Illinois, United States +9 more locations

COMPLETEDPhase 253 miles

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

NCT00051844

This is a 48 week study that is intended for HIV Infected persons whose first treatment regimen was with a nonnucleoside reverse transcriptase inhibitor (NNRTI) and who are now failing that regimen. They must be currently on their failing regimen to be eligible.

Human Immunodeficiency Virus

Pfizer179 participantsStarted Aug 2002

Beverly Hills, California, United States • Long Beach, California, United States • Newport Beach, California, United States +49 more locations

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Find Trials by Condition in Georgia

Efficacy and Safety Study of XP12B in Women With Menorrhagia

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Clinical Study to Evaluate the Safety and Efficacy of the Vela100

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex